SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-A12G - Registration of securities [Section 12(g)]:
SEC Accession No. 0001493152-24-000038
Filing Date
2024-01-02
Accepted
2024-01-02 09:10:05
Documents
7

Document Format Files

Seq Description Document Type Size
1 form8a12g.htm 8-A12G 36268
2 ex4-1.htm EX-4.1 445746
3 ex4-1_001.jpg GRAPHIC 26954
4 ex4-1_002.jpg GRAPHIC 28331
5 ex4-1_003.jpg GRAPHIC 21401
6 ex4-1_004.jpg GRAPHIC 21967
7 ex4-1_005.jpg GRAPHIC 20895
  Complete submission text file 0001493152-24-000038.txt   646088
Mailing Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731
Business Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

IRS No.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-A12G | Act: 34 | File No.: 000-29959 | Film No.: 24500531
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)